NCT00247156

Brief Summary

1\. We hypothesize that children in the experimental group will show a significant improvement over the control group as all food allergens groups and some other relevant allergenic substances are desensitized in a systematic way using the NAET® methodology within the specified period of study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Nov 2004

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2004

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

October 31, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 1, 2005

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2005

Completed
Last Updated

June 26, 2008

Status Verified

April 1, 2006

First QC Date

October 31, 2005

Last Update Submit

June 25, 2008

Conditions

AutismFood Allergies

Keywords

Autismeye contactNoncommunicable

Outcome Measures

Primary Outcomes (1)

  • Improvement in speech and communication

Secondary Outcomes (1)

  • Elimination or reduction of commonly seen autistic traits

Interventions

Acupressure treatments and NAET treatmentsPROCEDURE

Eligibility Criteria

Age3 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may not qualify if:

  • Any child that has a history of various complications of illness other than autism spectrum disorder would be disqualified. Previously treated with NAET treatments for this condition will be disqualified to enroll in the study. Any patient who has any of the following incidents will also be disqualified.
  • Previous surgeries, congenital deformities of heart, lung, liver, brain, kidney, etc.
  • Any type of cancer
  • Aids
  • Any physically debilitating disorders and diagnosed mental retardation, Down's syndrome, etc.
  • Children with the history of severe allergies or anaphylactic reactions will be rejected.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PNIB Research Center

Buena Park, California, 90621, United States

Location

MeSH Terms

Conditions

Autistic DisorderFood Hypersensitivity

Condition Hierarchy (Ancestors)

Autism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental DisordersMental DisordersHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Devi S. Nambudripad, LAc, PhD

    The journal of NAET Energetics and Complementary Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 31, 2005

First Posted

November 1, 2005

Study Start

November 1, 2004

Study Completion

November 1, 2005

Last Updated

June 26, 2008

Record last verified: 2006-04

Locations

US(1)